What patient factors prompt you to consider starting dupilumab in patients with COPD?
Does active smoking status influence this decision?
Community PollStarted
Does smoking status influence your decision to start dupilumab in patients with COPD?
31 physicians have voted
Join Mednetto vote and see how they answered.
2 Answers
Mednet MemberInvited Expert
Pulmonology · Columbia Doctors Pulmonology
Answered on
The factors I consider are recurrent exacerbations, symptoms despite triple therapy, and an eosinophil count that is greater than 300.
What is unclear is the decision regarding chronic azithromycin and/or roflumilast versus dupilumab. It looks like roflumilast was not allowed in the study, and appar...
Join for free or sign in to see the full answer
Mednet Member
Pulmonology · Mount Sinai School of Medicine
Answered on
I look at the history of exacerbations despite LABA/LAMA/ICS compliance.
Join for free or sign in to see the full answer